Bitemedicine Flashcards
Symptoms of hyperviscousity
Headache, blurred vision, flushing, palmar erythema, itching after a bath, burning pain in extremities, increased risk of thrombosis
Medication in patients with polycythaemia vera
Aspirin
EPO levels in polycythaemia vera
Low (negative feedback)
Mutation in 95% of patients with polycytaemia vera
JAK2
Management of polycythaemia vera
Weekly phlebotomy
Aspirin
Hydroxyurea (in patients at very high risk of thrombosis e.g. older age)
Symptoms of polycythaemia vera
Headache, blurred vision, flushing, palmar erythema, itching after a bath, burning pain in extremities, increased risk of thrombosis
Pathophysiology of essential thrombocytosis
Proliferation of megakaryocytes increases platelet count
Symptoms of essential thrombocytosis
Bleeding (platelets dysfunctional)
Clotting (more platelets)
Mutation seen in 50% of patients with essential thrombocytosis
JAK2
Bone marrow biopsy in essential thrombocytosis
Increased megakaryocytes
Management of essential thrombocytosis
Aspirin
Hydroxyurea
Which haematological malignancy is gum hypertrophy most associated with?
AML
What condition does myelodysplasia predispose to?
AML
Translocation associated with AML
t(15;17)
Features of the acute promyelocytic leukaemia subtype of AML
Younger patients (around 45yrs)
Associated with DIC
t(15;17) translocation
Good prognosis
What is myelodysplasia?
Neoplastic proliferation of immature myeloid cells with evidence of dysplasia
30% progress to AML
Bone marrow biopsy in myelodysplasia
Blast cells raised but less than 20%
Blood film in AML
Immature myeloid cells
Auer rods
Bone marrow biopspy in AML
More than 20% myeloblasts
Genetics of CML
Philadelphia chromosome common (causes BCR-ABL gene)
Blood film in CML
Raised granulocytes, but most of these aren’t blasts
Bone marrow biopsy in CML
Raised granulocytes, but most of these aren’t blasts
Blast cell count in chronic phase CML
Less than 10% blast cells
Blast cell count in accelerated phase CML
Less than 20% blast cells
Blast cell count in blast phase CML
Over 20% blast cells
What is myelofibrosis?
Myeloproliferative condition whereby there is neoplastic proliferation of mature myeloid cells, particularly megakaryocytes, leading to marrow fibrosis
Risk factors for myelofibrosis
Older age
Radiation
Mutation seen in around 50% of patients with myelofibrosis
JAK2
Teardrop RBCs of blood film
Myelofibrosis
FBC in myelofibrosis
Anaemia, others are low or variable
Bone marrow aspirate and biopsy in myelofibrosis
“dry tap” on aspirate
marrow fibrosis on biopsy
Management of myelofibrosis
Chemotherapy
What age does polycythaemia vera tend to onset?
50-70
What are actinic keratoses?
Pre-malignant scaly spots on the skin
Dues to sun exposure
May develop into squamous cell carcinoma
SCC prognosis
Good
Risk factors for malignant melanoma
Older age (not so significant as BCC or SCC Sun exposure Previous skin cancer Family history of skin cancer Fair skin Multiple / atypical moles Immunosuppression
What is the most common type of melanoma?
Superficial spreading
Characteristics of superficial spreading melanoma
Grows horizontally before deepe
Younger patient
Back, chest, arms, legs
Flat, large, irregularly pigmented
Characteristics of nodular malignant melanoma
Rapidly growing
Middle aged
Sun exposed areas
Pigmented nodule may bleed and ulcerate
Symptoms of malignant melanoma
Large size Dark Uneven boarders Sensory changes eg itching Crusting/ bleeding Systemic symptoms
Management of malignant melanoma
Excision
Topical adjuvant chemotherapy
Lymph node clearance (if involved)
Systemic adjuvant chemotherapy (if high grade)
First line in PE
Rivaroxaban
Management of asymptomatic primary PE <2cms
Disacharge and review in clinic
Management of symptomatic or >2cms primary PE
aspirate with 16-18G cannula
Management of unsuccessful aspiration of primary Pneumothorax
Chest drain and admit
Management of secondary PE <1cm
Admit for high flow O2 and observe
Management of secondary PE 1-2 cm
aspirate with 16-18G cannula
Management of unsuccessful aspiration of secondary PE
Chest drain and admit
Management of secondary Pneumothorax >2cms
Chest drain and admit
Management of undisplaced intracapsular hip fracture without significant comorbidities
Internal fixation with dynamic hip screw
Management of undisplaced intracapsular hip fracture with significant comorbidities
Hemiarthroplasty
Management of displaced intracapsular hip fracture without significant comorbidities
Total hip replacement
Management of displaced intracapsular hip fracture with significant comorbidities
Hemiarthroplasty
Management of intertrochanteric hip fracture
Internal fixation with dynamic hip screw
Management of subtrochanteric hip fracture
Internal fixation with intermedullary nail
Organism that causes pneumonia with red sputum
Klebsiella
Gender more common in PSC
Males
Gender more common in PBC
Female
Treatment of cluster headaches
High flow O2 and SC or nasal triptan
Which haematological malignancy is associated with gum hypertrophy
AML
Risk factors for PBC
Middle aged female
Other autoimmune conditions
Risk factors for PSC
Middle aged male
IBD
Presentation of PSC
Often asymptomatic Fatigue Pruritis Jaundice Hepatomegaly
Presentation of PBC
Often asymptomatic Fatigue Pruritis Jaundice Hepatomegaly
Antibodies in PBC
Anti-mitochondrial antibodies (AMA)
Antibodies in PSC
pANCA
Imaging in PBC
Abdo US
Imaging in PSC
ERCP
Management of PBC
Ursodeoxycholic acid
Cholestyramine
Replace fat soluble vitamins
Liver transplant if end stage
Management of PSC
Cholestyramine
Replace fat soluble vitamins
Liver transplant if end stage
Management of high risk HPV but no cell changes on cervical screening
Repeat HPV smear in a year. If no high risk HPV then return to routine screening. If high risk HPV then look for cell changes. If cellular changes, refer to colposcopy. If no cell changes then further smear in 2 years and refer to colposcopy if still positive for HPV
Management of inconclusive smear
Repeat in 3 months. If still inconclusive refer for colposcopy
Management of asymptomatic gallstones
Reassurance
Tumour marker to monitor pancreatic cancer
CA19-9
First line in peripheral arterial disease
Supervised exercise programme
First line in acne vulgaris
Topical retinoids or topical clindamycin with or without topical benzoyl peroxide
Mental health screen and education
Second line in acne vulgaris
Oral doxycycline or COCP
First line in mild acne rosacea
Topical abx
First line in moderate / severe acne rosacea
Oral abx
Symptoms of acne rosacea
Papules / pustules
Telangiectasia
Flushing
Medications to avoid in acne rosacea
Vasodilator meds
Symptoms of seborrheic dermatitis
Redness over nose that may spread
Dandruff
First line in seborrheic dermatitis
Anti-fungal shampoo and cream
Symptoms of pityriasis rosea
Initial oval herald patch followed by widespread rash
Management of pityriasis rosea
Reassurance. May offer symptom relief e.g. creams
Symptoms of lichen planus
Purple itchy rash on the wrists with oral involvement
Management of lichen planus
Topical steroids
Demographic of bullous pemphigoid
Older
Management of bullous pemphigoid
Oral steroids
Management of pemphigus vulgaris
Oral steroids
When to check urate in gout
4-6 weeks after attack
Key antibodies in Sjogren’s syndrome
anti-Ro, anti-La
Treatment for Sjogren’s syndrome
Symptomatic e.g. eyedrops
DMARDs
Symptoms of dermatomyositis
Proximal muscle aches and weakness
Rash (typically purple rash on eyelids)
Papules over finger joints
Oedema
Creatinine kinase in dermatomysitis
Raised
Management of dermatomyositis
Steroids
Avoid sun exposure and topical steroids for rash
Features of scleroderma
Calcinosis Raynauds Oesophageal dysmotility Tight skin Telangiectasia